IBDEI1A7 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22702,0)
 ;;=625.2^^125^1396^39
 ;;^UTILITY(U,$J,358.3,22702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22702,1,4,0)
 ;;=4^625.2
 ;;^UTILITY(U,$J,358.3,22702,1,5,0)
 ;;=5^Ovulation Pain
 ;;^UTILITY(U,$J,358.3,22702,2)
 ;;=Ovulation Pain^265259
 ;;^UTILITY(U,$J,358.3,22703,0)
 ;;=614.9^^125^1396^42
 ;;^UTILITY(U,$J,358.3,22703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22703,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,22703,1,5,0)
 ;;=5^Pelvic inflammatory disease
 ;;^UTILITY(U,$J,358.3,22703,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,22704,0)
 ;;=789.30^^125^1396^40
 ;;^UTILITY(U,$J,358.3,22704,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22704,1,4,0)
 ;;=4^789.30
 ;;^UTILITY(U,$J,358.3,22704,1,5,0)
 ;;=5^Pelvic Mass
 ;;^UTILITY(U,$J,358.3,22704,2)
 ;;=Pelvic Mass^917
 ;;^UTILITY(U,$J,358.3,22705,0)
 ;;=622.7^^125^1396^44
 ;;^UTILITY(U,$J,358.3,22705,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22705,1,4,0)
 ;;=4^622.7
 ;;^UTILITY(U,$J,358.3,22705,1,5,0)
 ;;=5^Polyp of Cervix
 ;;^UTILITY(U,$J,358.3,22705,2)
 ;;=Polyp of Cervix^79612
 ;;^UTILITY(U,$J,358.3,22706,0)
 ;;=627.1^^125^1396^45
 ;;^UTILITY(U,$J,358.3,22706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22706,1,4,0)
 ;;=4^627.1
 ;;^UTILITY(U,$J,358.3,22706,1,5,0)
 ;;=5^Postmenopausal bleeding
 ;;^UTILITY(U,$J,358.3,22706,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,22707,0)
 ;;=V24.2^^125^1396^46
 ;;^UTILITY(U,$J,358.3,22707,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22707,1,4,0)
 ;;=4^V24.2
 ;;^UTILITY(U,$J,358.3,22707,1,5,0)
 ;;=5^Postpartum
 ;;^UTILITY(U,$J,358.3,22707,2)
 ;;=Postpartum^114052
 ;;^UTILITY(U,$J,358.3,22708,0)
 ;;=V22.2^^125^1396^47
 ;;^UTILITY(U,$J,358.3,22708,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22708,1,4,0)
 ;;=4^V22.2
 ;;^UTILITY(U,$J,358.3,22708,1,5,0)
 ;;=5^Pregnancy Status
 ;;^UTILITY(U,$J,358.3,22708,2)
 ;;=Pregnancy Status^97923
 ;;^UTILITY(U,$J,358.3,22709,0)
 ;;=627.0^^125^1396^48
 ;;^UTILITY(U,$J,358.3,22709,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22709,1,4,0)
 ;;=4^627.0
 ;;^UTILITY(U,$J,358.3,22709,1,5,0)
 ;;=5^Premenopausal menorrhagia
 ;;^UTILITY(U,$J,358.3,22709,2)
 ;;=^270575
 ;;^UTILITY(U,$J,358.3,22710,0)
 ;;=625.4^^125^1396^49
 ;;^UTILITY(U,$J,358.3,22710,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22710,1,4,0)
 ;;=4^625.4
 ;;^UTILITY(U,$J,358.3,22710,1,5,0)
 ;;=5^Premenstrual tension
 ;;^UTILITY(U,$J,358.3,22710,2)
 ;;=^98014
 ;;^UTILITY(U,$J,358.3,22711,0)
 ;;=302.70^^125^1396^51
 ;;^UTILITY(U,$J,358.3,22711,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22711,1,4,0)
 ;;=4^302.70
 ;;^UTILITY(U,$J,358.3,22711,1,5,0)
 ;;=5^Sexual dysfunction, psychosexual
 ;;^UTILITY(U,$J,358.3,22711,2)
 ;;=^100647
 ;;^UTILITY(U,$J,358.3,22712,0)
 ;;=599.0^^125^1396^55
 ;;^UTILITY(U,$J,358.3,22712,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22712,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,22712,1,5,0)
 ;;=5^Urinary Tract Infection
 ;;^UTILITY(U,$J,358.3,22712,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,22713,0)
 ;;=218.9^^125^1396^56
 ;;^UTILITY(U,$J,358.3,22713,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22713,1,4,0)
 ;;=4^218.9
 ;;^UTILITY(U,$J,358.3,22713,1,5,0)
 ;;=5^Uterine Fibroids
 ;;^UTILITY(U,$J,358.3,22713,2)
 ;;=Uterine Fibroids^68944
 ;;^UTILITY(U,$J,358.3,22714,0)
 ;;=618.1^^125^1396^57
 ;;^UTILITY(U,$J,358.3,22714,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22714,1,4,0)
 ;;=4^618.1
 ;;^UTILITY(U,$J,358.3,22714,1,5,0)
 ;;=5^Uterine Prolapse
 ;;^UTILITY(U,$J,358.3,22714,2)
 ;;=Uterine Prolapse^124773
 ;;^UTILITY(U,$J,358.3,22715,0)
 ;;=623.0^^125^1396^58
 ;;^UTILITY(U,$J,358.3,22715,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI1A7
